Rheumatology · Ocala, FL
NPI
1932191541
Since 2005
Specialty
Rheumatology
Code 174400000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
3304 SW 34th Cir, Suite 103
Ocala, FL, 34474
Phone (352) 291-0245
Groups this clinician bills Medicare through
Medicare paid, 2024
$834K
94,748 services
Medicare patients, 2024
538
Average age 75
Drug cost, 2024
$3.6M
3,942 prescriptions
Company payments, 2025
$393
From 3 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Thomas E Lafferty was code J1010 (injection, methylprednisolone acetate, 1 mg), 13,252 times for 107 patients. In total Thomas E Lafferty billed 94,748 services in 106 codes, and Medicare paid $834K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2014-01-09.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J1010 Injection, methylprednisolone acetate, 1 mg | Office | 13,252 | 107 | $0.10 | $1,355 |
| J0897 Injection, denosumab, 1 mg | Office | 4,260 | 44 | $20.22 | $86K |
| J1745 Injection, infliximab, excludes biosimilar, 10 mg | Office | 1,980 | 11 | $25.01 | $50K |
| J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 1,280 | 94 | $0.71 | $915 |
| 99214 Office E&M - Established | Office | 803 | 384 | $88.22 | $71K |
| 86235 Immunoassay | Office | 747 | 94 | $17.57 | $13K |
| 96372 Injection Administration | Office | 481 | 226 | $10.40 | $5,002 |
| 85651 Clinical Chemistry | Office | 406 | 251 | $4.18 | $1,697 |
| 86140 Clinical Chemistry | Office | 405 | 251 | $5.08 | $2,057 |
| 85025 Blood Count | Office | 396 | 255 | $7.61 | $3,014 |
| 80076 Clinical Chemistry | Office | 324 | 216 | $8.01 | $2,595 |
| 97140 PT Treatment | Office | 304 | 29 | $15.86 | $4,823 |
| 86147 Immunoassay | Office | 288 | 95 | $24.94 | $7,183 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 252 | 198 | $12.87 | $3,243 |
| 86160 Immunoassay | Office | 214 | 102 | $11.76 | $2,517 |
By year: 2022 $940K for 75,265 services; 2023 $803K for 72,936 services; 2024 $834K for 94,748 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 86235 Immunoassay | 747 | 94 | $17.57 | $13K |
| 85651 Clinical Chemistry | 406 | 251 | $4.18 | $1,697 |
| 86140 Clinical Chemistry | 405 | 251 | $5.08 | $2,057 |
| 85025 Blood Count | 396 | 255 | $7.61 | $3,014 |
| 80076 Clinical Chemistry | 324 | 216 | $8.01 | $2,595 |
| 86147 Immunoassay | 288 | 95 | $24.94 | $7,183 |
| 86160 Immunoassay | 214 | 102 | $11.76 | $2,517 |
| 86146 Immunoassay | 192 | 95 | $24.94 | $4,788 |
| 80048 Clinical Chemistry | 192 | 137 | $8.29 | $1,592 |
| 82565 Clinical Chemistry | 175 | 142 | $5.02 | $879 |
Medicare prescription drug claims, 2024
In 2024, the drug Thomas E Lafferty prescribed most often to Medicare patients was Gabapentin, with 407 prescriptions and refills. In total Thomas E Lafferty wrote 3,942 Medicare prescriptions that cost $3.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Gabapentin Generic | 407 | 666 | 108 | $5,806 |
| Methotrexate Methotrexate Sodium | 372 | 870 | 115 | $9,351 |
| Prednisone Generic | 358 | 628 | 102 | $2,740 |
| Hydroxychloroquine Sulfate Generic | 315 | 761 | 97 | $13K |
| Celecoxib Generic | 256 | 525 | 90 | $7,928 |
| Methylprednisolone Generic | 223 | 280 | 93 | $2,819 |
| Tizanidine Hcl Generic | 185 | 380 | 72 | $2,490 |
| Meloxicam Generic | 170 | 271 | 55 | $756 |
| Diclofenac Sodium Generic | 144 | 192 | 62 | $3,147 |
| Tramadol Hcl Generic | 122 | 148 | 27 | $2,445 |
| Enbrel Sureclick Etanercept | 113 | 140 | 18 | $1.0M |
| Duloxetine Hcl Generic | 93 | 171 | 25 | $1,485 |
| Pregabalin Generic | 87 | 113 | 23 | $1,311 |
| Nabumetone Generic | 79 | 110 | 30 | $928 |
| Folic Acid Generic | 77 | 192 | 28 | $658 |
Brand drugs: - claims; generic drugs: 3,432 claims; opioid claims: 145.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Thomas E Lafferty $393 ($393 in general payments such as food, travel and fees) from 3 companies. The largest payer was UCB, Inc. with $147.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.